Abscisic acid stimulates glucagon-like peptide-1 secretion from L-cells and its oral administration increases plasma glucagon-like peptide-1 levels in rats

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Bruzzone, Santina ^a   Magnone, Mirko ^a   Mannino, Elena ^a   Sociali, Giovanna ^a   Sturla, Laura ^a   Fresia, Chiara ^a   Booz, Valeria ^a   Emionite, Laura ^b   De Flora, Antonio ^a   Zocchi, Elena ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABSCISIC ACID; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; LANCL2 PROTEIN, HUMAN; MEMBRANE PROTEIN; NUCLEAR PROTEIN;

ANIMAL EXPERIMENT; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE HOMEOSTASIS; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; INSULIN BLOOD LEVEL; L CELL LINE; NONHUMAN; POSITIVE FEEDBACK; RAT; SINGLE DRUG DOSE; ANIMAL; BLOOD; DRUG EFFECTS; ENTEROENDOCRINE CELL; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; ORAL DRUG ADMINISTRATION; SECRETION (PROCESS); TUMOR CELL LINE; WISTAR RAT;

ABSCISIC ACID; ADMINISTRATION, ORAL; ANIMALS; BLOOD GLUCOSE; CELL LINE, TUMOR; CYCLIC AMP; ENTEROENDOCRINE CELLS; FEMALE; GLUCAGON-LIKE PEPTIDE 1; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MEMBRANE PROTEINS; NUCLEAR PROTEINS; RATS; RATS, WISTAR;

EID: 84949921087     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0140588     Document Type: Article

References (32)

1. Hong JH, Seah SW, Xu J. The root of ABA action in environmental stress response. Plant Cell Rep. 2013; 32: 971-983. doi: 10.1007/s00299-013-1439-9 PMID: 23571661
2. Lee SC, Luan S. ABA signal transduction at the crossroad of biotic and abiotic stress responses. Plant Cell Environ. 2012; 35: 53-60. doi: 10.1111/j.1365-3040.2011.02426.x PMID: 21923759
3. Bruzzone S, Moreschi I, Usai C, Guida L, Damonte G, Salis A, et al. Abscisic acid is an endogenous cytokine in human granulocytes with cyclic ADP-ribose as second messenger. Proc Natl Acad Sci USA 2007; 104: 5759-5764. PMID: 17389374
4. Bruzzone S, Bodrato N, Usai C, Guida L, Moreschi I, Nano R, et al. (2008) Abscisic acid is an endogenous stimulator of insulin release from human pancreatic islets with cyclic ADP ribose as second messenger. J Biol Chem. 2008; 283: 32188-32197. doi: 10.1074/jbc.M802603200 PMID: 18784081
5. Bruzzone S, Ameri P, Briatore L, Mannino E, Basile G, Andraghetti G, et al. The plant hormone abscisic acid increases in human plasma after hyperglycemia and stimulates glucose consumption by adipocytes and myoblasts. FASEB J 2012; 26: 1251-1260. doi: 10.1096/fj.11-190140 PMID: 22075645
6. Tossi V, Cassia R, Bruzzone S, Zocchi E, Lamattina L. ABA says NO to UV-B: a universal response? Trends Plant Sci 2012; 17:510-517. doi: 10.1016/j.tplants.2012.05.007 PMID: 22698377
7. Sturla L, Fresia C, Guida L, Bruzzone S, Scarfì S, Usai C, et al. LANCL2 is necessary for abscisic acid binding and signaling in human granulocytes and in rat insulinoma cells. J Biol Chem. 2009; 284, 28045-28057. doi: 10.1074/jbc.M109.035329 PMID: 19667068
8. Sturla L, Fresia C, Guida L, Grozio A, Vigliarolo T, Mannino E, et al. Binding of abscisic acid to human LANCL2. Biochem Biophys Res Commun. 2011; 415: 390-395. doi: 10.1016/j.bbrc.2011.10.079 PMID: 22037458
9. Bassaganya-Riera J, Guri AJ, Lu P, Climent M, Carbo A, Sobral BW, et al. Abscisic acid regulates inflammation via ligand-binding domain-independent activation of peroxisome proliferator-activated receptor gamma. J Biol Chem. 2011; 286: 2504-2516. doi: 10.1074/jbc.M110.160077 PMID: 21088297
10. Bruzzone S, Basile G, Mannino E, Sturla L, Magnone M, Grozio A, et al. Autocrine abscisic acid mediates the UV-B-induced inflammatory response in human granulocytes and keratinocytes. J Cell Physiol. 2012; 227: 2502-2501. doi: 10.1002/jcp.22987 PMID: 21898394
11. Bruzzone S, Battaglia F, Mannino E, Parodi A, Fruscione F, Basile G, et al. Abscisic acid ameliorates the systemic sclerosis fibroblast phenotype in vitro. Biochem Biophys Res Commun. 2012; 422: 70-74. doi: 10.1016/j.bbrc.2012.04.107 PMID: 22560900
12. Magnone M, Bruzzone S, Guida L, Damonte G, Millo E, Scarfì S, et al. Abscisic acid released by human monocytes activates monocytes and vascular smooth muscle cells responses involved in atherogenesis. J Biol Chem. 2009; 284: 17808-17818. doi: 10.1074/jbc.M809546200 PMID: 19332545
13. Guri AJ, Hontecillas R, Si H, Liu D, Bassaganya-Riera J. Dietary abscisic acid ameliorates glucose tolerance and obesity-related inflammation in db/db mice fed high-fat diets. Clin Nutr. 2007; 26: 107-116. PMID: 17000034
14. Ezcurra M, Reimann F, Gribble FM, Emery E. Molecular mechanisms of incretin hormone secretion. Curr Opin Pharmacol. 2013; 13: 922-927. doi: 10.1016/j.coph.2013.08.013 PMID: 24035446
15. Sandoval DA, D'Alessio DA. Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease. Physiol Rev. 2015; 95:513-548. doi: 10.1152/physrev.00013.2014 PMID: 25834231
16. Velàsquez DA, Beiroa D, Vàzquez MJ, Romero A, Lòpez M, Diéguez C, et al. Central GLP-1 actions on energy metabolism. Vitam Horm. 2010; 84: 303-317. doi: 10.1016/B978-0-12-381517-0.00011-4 PMID: 21094905
17. Reimer RA, Darimont C, Gremlich S, Nicolas-Métral V, Rüegg UT, Macé K. A human cellular model for studying the regulation of glucagon-like peptide-1 secretion. Endocrinology. 2001; 142: 4522-4528. PMID: 11564718
18. Moreschi I, Bruzzone S, Nicholas RA, Fruscione F, Sturla L, Benvenuto F, et al. Extracellular NAD+ is an agonist of the human P2Y11 purinergic receptor in human granulocytes. J Biol Chem. 2006; 281: 31419-31429. PMID: 16926152
19. Vigliarolo T, Guida L, Millo E, Fresia C, Turco E, De Flora A, et al. Abscisic Acid transport in Human Erythrocytes. J Biol Chem. 2015; 290: 13042-13052. doi: 10.1074/jbc.M114.629501 PMID: 25847240
20. Forest T, Holder D, Smith A, Cunningham C, Yao X, Dey M, Frederick C, Prahalada S. Characterization of the exocrine pancreas in the male Zucker diabetic fatty rat model of type 2 diabetes mellitus following 3 months of treatment with sitagliptin. Endocrinology 2014; 155: 783-792. doi: 10.1210/en.2013-1781 PMID: 24424056
21. Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, Sugimoto Y, Miyazaki S, Tsujimoto G. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med. 2005; 11:90-94. PMID: 15619630
22. Jang HJ, Kokrashvili Z, Theodorakis MJ, Carlson OD, Kim BJ, Zhou J, et al. Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proc Natl Acad Sci USA 2007; 104: 15069-15074. PMID: 17724330
23. Reimann F, Williams L, da Silva Xavier G, Rutter GA, Gribble FM. Glutamine potently stimulates glucagon-like peptide-1 secretion from GLUTag cells. Diabetologia 2004; 47: 1592-1601. PMID: 15365617
24. Guri AJ, Misyak SA, Hontecillas R, Hasty A, Liu D, Si H, et al. Abscisic acid ameliorates atherosclerosis by suppressing macrophage and CD4+ T cell recruitment into the aortic wall. J Nutr Biochem. 2010; 21: 1178-1185. doi: 10.1016/j.jnutbio.2009.10.003 PMID: 20092994
25. Guri AJ, Hontecillas R, Bassaganya-Riera J. Abscisic acid synergizes with rosiglitazone to improve glucose tolerance and down-modulate macrophage accumulation in adipose tissue: possible action of the cAMP/PKA/PPAR γ axis. Clin Nutr. 2010; 29: 646-653. doi: 10.1016/j.clnu.2010.02.003 PMID: 20207056
26. Tolhurst G, Zheng Y, Parker HE, Habib AM, Reimann F, Gribble FM. Glutamine triggers and potentiates glucagon-like peptide-1 secretion by raising cytosolic Ca2+ and cAMP. Endocrinology 2011; 152: 405-413. doi: 10.1210/en.2010-0956 PMID: 21209017
27. Saha JK, Xia J, Grondin JM, Engle SK, Jakubowski JA. Acute hyperglycemia induced by ketamine/ xylazine anesthesia in rats: mechanisms and implications for preclinical models. Exp Biol Med. 2005; 230: 777-784.
28. Zeng M, van der Donk WA, Chen J. Lanthionine synthetase C-like protein 2 (LanCL2) is a novel regulator of Akt. Mol Biol Cell. 2014; 25: 3954-3961. doi: 10.1091/mbc.E14-01-0004 PMID: 25273559
29. Ishiki M., Klip A. Minireview: recent developments in the regulation of glucose transporter-4 traffic: new signals, locations, and partners. Endocrinology 2005; 146: 5071-5078. PMID: 16150904
30. Lu P, Hontecillas R, Philipson CW, Bassaganya-Riera J. Lanthionine synthetase component C-like protein 2: a new drug target for inflammatory diseases and diabetes. Curr Drug Targets. 2014; 15: 565-572. PMID: 24628287
31. Lu P, Hontecillas R, Horne WT, Carbo A, Viladomiu M, Pedragosa M, Bevan DR, Lewis SN, Bassaganya-Riera J. Computational modeling-based discovery of novel classes of anti-inflammatory drugs that target lanthionine synthetase C-like protein 2. PLoS One. 2012; 7: e34643. doi: 10.1371/journal.pone. 0034643 PMID: 22509338
32. Bruzzone S, De Flora A, Grozio A, Guida L, Millo E, Magnone M, Salis A, Zocchi E. Synthetic analogues of abscisic acid with anti-inflammatory and insulin release stimulation effects on human cells. EP 2511272 B1, 2015-04-15.